Metabolic and hormonal interactions between muscle and adipose tissue

Proceedings of the Nutrition Society

Volumn 63, Issue 2, 2004, Pages 381-385

  Tomas, Eva ^a   Kelly, Mechan ^a   Xiang, Xiaoqin ^a   Tsao, Tsu Shuen ^c   Keller, Charlotte ^b   Keller, Pernille ^b   Luo, Zhijun ^a   Lodish, Harvey ^c,d   Saha, Asish K ^a   Unger, Roger ^e   Ruderman, Neil B ^a  

^a BOSTON UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c WHITEHEAD INSTITUTE FOR BIOMEDICAL RESEARCH   (United States)

^d MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^e UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Adiponectin; AMP activated protein kinase; Energy homeostasis; IL 6; Insulin resistance; Malonyl CoA

Indexed keywords

ADIPONECTIN; FATTY ACID; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; INTERLEUKIN 6; LEPTIN; LEPTIN RECEPTOR;

ADIPOCYTE; ADIPOSE TISSUE; ANIMAL TISSUE; ATHEROSCLEROSIS; CONFERENCE PAPER; ENDOCRINE GLAND; ENERGY; ENZYME ACTIVATION; EXERCISE; FATTY ACID OXIDATION; HORMONE ACTION; INSULIN RESISTANCE; LIPOLYSIS; METABOLISM; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; NUTRIENT; OBESITY; PROTEIN DEFICIENCY; SKELETAL MUSCLE;

ADIPONECTIN; ADIPOSE TISSUE; ENERGY METABOLISM; HUMANS; INSULIN RESISTANCE; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; INTERLEUKIN-6; LEPTIN; LIPID METABOLISM; LIPOLYSIS; MUSCLE, SKELETAL;

ANIMALIA;

EID: 2942748585     PISSN: 00296651     EISSN: None     Source Type: Journal    
DOI: 10.1079/PNS2004356     Document Type: Conference Paper

References (29)

1. Arita Y, Kihara S, Ouchi N, Takahashi M, Meada K, Miyagawa J, Hotta K, Shimomura I, Nakamura I & Miyaoka K (1999) Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochemical and Biophysical Research Communications 257, 79-83.
2. Arner P (2003) The adipocyte in insulin resistance: key molecules and the impact of the thiazolidinediones. Trends in Endocrinology and Metabolism 14, 137-145.
3. Berg A, Combs TP, Du X, Brownlee M & Scherer PE (2001) The adipocyte-secreted protein Acrp30 enhances hepatic insulin action. Nature Medicine 7, 947-952.
4. Berg AH, Combs TP & Scherer E (2002) ACRP30/adiponectin: an adipokine regulating glucose and lipid metabolism. Trends in Endocrinology and Metabolism 13, 84-89.
5. Fruebis J, Tsao T-S, Javorschi S, Ebbets-Reed D, Erickson MR, Yen FT, Bihain BE & Lodish H (2001) Proteolytic cleavage product of 30-kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice. Proceedings of the National Academy of Sciences USA 4, 2005-2010.
6. Gong D, Yang R, Munir KM, Horenstein RB & Shuldiner AR (2003) New progress in adipocytokine research. Current Opinion in Endocrinology and Diabetes 10, 115-121.
7. Halaas JL, Gajiwala KS, Maffei M, Cohen SL, Chait BT, Rabinowitz D, Lallone RL, Burley SK & Friedman JM (1995) Weight-reducing effects of the plasma protein encoded by the obese gene. Science 269, 543-546.
8. Hotta K, Funahashi T, Arita Y, Takahashi M, Matsuda M, Okamoto Y, Iwahashi H, Kuriyama H, Ouchi N & Maeda K (2000) Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arteriosclerosis, Thrombosis and Vascular Biology 20, 1595-1599.
9. Hu E, Liang P & Spiegelman BM (1996) AdipoQ is a novel adipose-specific gene dysregulated in obesity. Journal of Biological Chemistry 18, 10697-10703.
10. Keller C, Steensberg A, Pilegaard H, Osada T, Saltin B, Pedersen BK & Neufer PD (2001) Transcriptional activation of the IL-6 gene in human contracting skeletal muscle: influence of muscle glycogen content. FASEB Journal 15, 2748-2750.
11. Lee Y, Hirose H, Ohneda M, Johnson JH, McGarry JD & Unger RH (1994) Beta-cell lipotoxicity in the pathogenesis of non-insulin-dependent diabetes mellitus: impairment in adipocyte-beta cell relationships. Proceedings of the National Academy of Sciences USA 91, 10878-10882.
12. Maeda N, Shimomurs I, Kishida K, Nishizawa H, Matsuda M, Nagaretani H et al. (2002) Diet-induced insulin resistance in mice lacking adiponectin/ACRP30. Nature Medicine 7, 731-737.
13. Minokoshi Y, Kim YB, Peroni OD, Fryer LG, Muller C, Carling D & Kahn BB (2002) Leptin stimulates fatty-acid oxidation by activating AMP-activated protein kinase. Nature 415, 339-343.
14. Muoio DM, Seefeld K, Witters LA & Coleman RA (1999) AMP-activated kinase reciprocally regulates triacylglycerol synthesis and fatty acid oxidation in liver and muscle: evidence that sn-glycerol-3-phosphate acyltransferase is a novel target. Biochemical Journal 338, 783-791.
15. Okamoto Y, Kihara S, Ouchi N, Nishida M, Arita Y, Kumada M et al. (2002) Adiponectin reduces atherosclerosis in apolipo-protein E-deficient mice. Circulation 106, 2767-2770.
16. Park H, Kaushik VK, Constant S, Prentki M, Przybytkowski E, Ruderman NB & Saha AK (2002) Coordinate regulation of malonyl-CoA decarboxylase, sn-glycerol-3-phosphate acyl-transferase, and acetyl-CoA carboxylase by AMP-activated kinase in rat tissues in response to exercise. Journal of Biological Chemistry 277, 32571-32577.
17. Scherer PE, Suzanne W, Fogliano M, Baldini G & Lodish HF (1995) A novel serum protein similar to C1q, produced exclusively in adipocytes. Journal of Biological Chemistry 45, 26746-26749.
18. Spiegelman BM & Flier JS (2001) Obesity and the regulation of energy balance. Cell 104, 531-543.
19. Starkie R, Ostrowski SR, Jauffred S, Febbraio M & Pedersen BK (2003) Exercise and IL-6 infusion inhibit endotoxin-induced TNF-alpha production in humans. FASEB Journal 8, 884-886.
20. Steensberg A, Keller C, Starkie RL, Osada T, Febbraio MA & Pedersen BK (2002) IL-6 and TNF-alpha expression in, and release from, contracting human skeletal muscle. American Journal of Physiology 283, E1272-E1278.
21. Steensberg A, van Hall G, Osada T, Sacchetti M, Saltin B & Pedersen KB (2000) Production of interleukin-6 in contracting human skeletal muscles can account for the exercise-induced increase in plasma interleukin-6. Journal of Physiology (London) 529, 237-242.
22. Tomas E, Tsao T-S, Saha AK, Murrey HE, Zhang CC, Itani SI, Lodish HF & Ruderman NB (2002) Enhanced muscle fat oxidation and glucose transport by ACRP30 globular domain: Acetyl-CoA carboxylase inhibition and AMP-activated protein kinase activation. Proceedings of the National Academy of Sciences USA 99, 16309-16313.
23. Tsao TS, Murrey HE, Hug C, Lee DH & Lodish HF (2002) Oligomerization state-dependent activation of NF-kappa B signaling pathway by adipocyte complement-related protein of 30kDa (Acrp30). Journal of Biological Chemistry 277, 29359-29362.
24. Van Hall G, Steensberg A, Sacchetti M, Fischer C, Keller C, Schjerling P, Hiscock N, Moller K, Saltin B, Febbraio MA & Pedersen BK (2003) Interleukin-6 stimulates lipolysis and fat oxidation in humans. Journal of Clinical Endocrinology and Metabolism 88, 3005-3010.
25. Wallenius V, Wallenius K, Ahren B, Rudling M, Carlsten H, Dickson SL, Ohlsson C & Jansson JO (2002) Interleukin-6 deficient mice develop mature-onset obesity. Nature Medicine 1, 75-79.
26. Wu X, Motoshina H, Mahadev K, Stalker TJ, Scalia R & Goldstein BJ (2003) Involvement of AMP-activated protein kinase in glucose stimulated by the globular domain of adiponectin in primary rat adipocytes. Diabetes 52, 1355-1363.
27. Yamauchi T, Kamon J, Minokoshi Y, Ito Y, Tsuchida A, Yokomizo T et al. (2003) Cloning of adiponectin receptors that mediate antidiabetic metabolic effects. Nature Medicine 423, 762-768.
28. Yamauchi T, Kamon J, Minokoshi Y, Ito Y, Waki H, Uchida S et al. (2002) Adiponectin stimulated glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nature Medicine 11, 1-8.
29. Yamauchi T, Kamon J, Waki H, Terauchi Y, Kubota N, Hara K et al. (2001) The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nature Medicine 8, 941-946.